These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 9474188)

  • 61. Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer.
    Bañez LL; Sun L; van Leenders GJ; Wheeler TM; Bangma CH; Freedland SJ; Ittmann MM; Lark AL; Madden JF; Hartman A; Weiss G; Castaños-Vélez E
    J Urol; 2010 Jul; 184(1):149-56. PubMed ID: 20478579
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
    Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS
    BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy.
    Bauer JJ; Connelly RR; Sesterhenn IA; Bettencourt MC; McLeod DG; Srivastava S; Moul JW
    Cancer; 1997 Mar; 79(5):952-62. PubMed ID: 9041158
    [TBL] [Abstract][Full Text] [Related]  

  • 64. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate.
    Theodorescu D; Broder SR; Boyd JC; Mills SE; Frierson HF
    J Urol; 1997 Jul; 158(1):131-7. PubMed ID: 9186339
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer.
    Bauer JJ; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Moul JW
    J Urol; 1996 Oct; 156(4):1511-6. PubMed ID: 8808919
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.
    Esposito V; Baldi A; De Luca A; Groger AM; Loda M; Giordano GG; Caputi M; Baldi F; Pagano M; Giordano A
    Cancer Res; 1997 Aug; 57(16):3381-5. PubMed ID: 9270000
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Risk factors for progression in patients with prostate cancer treated with radical prostatectomy.
    Lerner SE; Blute ML; Zincke H
    Semin Urol Oncol; 1996 May; 14(2 Suppl 2):12-20; discussion 21. PubMed ID: 8725887
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer.
    Yip PY; Kench JG; Rasiah KK; Benito RP; Lee CS; Stricker PD; Henshall SM; Sutherland RL; Horvath LG
    Prostate; 2011 Nov; 71(15):1638-45. PubMed ID: 21432866
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate.
    Theodorescu D; Broder SR; Boyd JC; Mills SE; Frierson HF
    Cancer; 1997 Dec; 80(11):2109-19. PubMed ID: 9392333
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cathepsin D and epidermal growth factor receptor immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy.
    Moul JW; Maygarden SJ; Ware JL; Mohler JL; Maher PD; Schenkman NS; Ho CK
    J Urol; 1996 Mar; 155(3):982-5. PubMed ID: 8583622
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Adjuvant treatment after radical prostatectomy in prostatic carcinoma (pT3 or pTxN+): prognostic factors and results].
    Zincke H
    Praxis (Bern 1994); 1997 Nov; 86(46):1825-32. PubMed ID: 9454284
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy.
    Compérat E; Rouprêt M; Drouin SJ; Camparo P; Bitker MO; Houlgatte A; Cancel-Tassin G; Cussenot O
    Prostate; 2010 Nov; 70(15):1622-7. PubMed ID: 20687232
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CD10 is inversely associated with nuclear factor-kappa B and predicts biochemical recurrence after radical prostatectomy.
    Voutsadakis IA; Vlachostergios PJ; Daliani DD; Karasavvidou F; Kakkas G; Moutzouris G; Melekos MD; Papandreou CN
    Urol Int; 2012; 88(2):158-64. PubMed ID: 22286396
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic significance of p27Kip1 expression in bladder cancer.
    Rabbani F; Koppie TM; Charytonowicz E; Drobnjak M; Bochner BH; Cordon-Cardo C
    BJU Int; 2007 Aug; 100(2):259-63. PubMed ID: 17555476
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy.
    Bubendorf L; Sauter G; Moch H; Schmid HP; Gasser TC; Jordan P; Mihatsch MJ
    J Pathol; 1996 Apr; 178(4):437-41. PubMed ID: 8691323
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.
    Masciullo V; Sgambato A; Pacilio C; Pucci B; Ferrandina G; Palazzo J; Carbone A; Cittadini A; Mancuso S; Scambia G; Giordano A
    Cancer Res; 1999 Aug; 59(15):3790-4. PubMed ID: 10446997
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma.
    Halvorsen OJ; Høstmark J; Haukaas S; Høisaeter PA; Akslen LA
    Cancer; 2000 Jan; 88(2):416-24. PubMed ID: 10640976
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy.
    Amamoto R; Yagi M; Song Y; Oda Y; Tsuneyoshi M; Naito S; Yokomizo A; Kuroiwa K; Tokunaga S; Kato S; Hiura H; Samori T; Kang D; Uchiumi T
    Cancer Sci; 2011 Mar; 102(3):639-47. PubMed ID: 21205079
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma.
    Cote RJ; Shi Y; Groshen S; Feng AC; Cordon-Cardo C; Skinner D; Lieskovosky G
    J Natl Cancer Inst; 1998 Jun; 90(12):916-20. PubMed ID: 9637141
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
    Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
    BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.